HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Safety and efficacy of temsirolimus under compassionate use in heavily pretreated patients with poor-prognosis solid tumors.

AuthorsJ P Fusco, C Rolfo, E Castañón, L Ceniceros, J Legaspi, J Espinós, J Rodríguez, J M Aramendía, M Santisteban, I Gil-Bazo
JournalMinerva chirurgica (Minerva Chir) Vol. 70 Issue 6 Pg. 495-8 (Dec 2015) ISSN: 1827-1626 [Electronic] Italy
PMID26657760 (Publication Type: Letter)
Chemical References
  • Antineoplastic Agents
  • temsirolimus
  • Sirolimus
Topics
  • Administration, Intravenous (methods)
  • Adult
  • Antineoplastic Agents (therapeutic use)
  • Breast Neoplasms (drug therapy, mortality, secondary)
  • Carcinoma (drug therapy, mortality, secondary)
  • Compassionate Use Trials (methods)
  • Endometrial Neoplasms (drug therapy, mortality, secondary)
  • Female
  • Follow-Up Studies
  • Humans
  • Liver Neoplasms (drug therapy, mortality, secondary)
  • Lung Neoplasms (drug therapy, mortality, secondary)
  • Male
  • Middle Aged
  • Retrospective Studies
  • Sirolimus (analogs & derivatives, therapeutic use)
  • Survival Analysis
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: